The group’s principle activity is to provide full-service, Phase I-IV global Contract research organization services for the pharmaceutical, biotechnology, and medical device companies. The group also provides a wide range of clinical services including clinical study design, strategic and regulatory consulting, project management, monitoring, clinical data management, biostatistics, pharmacokinetic and pharmacodynamic analysis services. The group operates from United States.
